goat anti-Helicobacter pylori antibodies

Goat anti-Helicobacter pylori antibodies are immunoglobulins produced in goats that specifically target and bind to the bacterium *Helicobacter pylori*. These antibodies are developed for therapeutic purposes, primarily to prevent or treat *Helicobacter pylori* infection, a condition associated with gastritis, peptic ulcers, and an increased risk of gastric cancer. The drug is notably administered orally, often in the form of milk containing these antibodies, which allows for passive immunization or direct neutralization of the bacteria within the gastrointestinal tract. The mechanism of action involves the antibodies binding to *H. pylori* antigens, thereby inhibiting bacterial adhesion to gastric cells and potentially leading to the elimination of the pathogen.

Other names

goat anti-Hp antibodies milk